MP Materials (MP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HA Sustainable Infrastructure Capital (HASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Recognition underscores Keysight's market leadership, customer-centric innovation, and pioneering role in accelerating 6G technology validation through AI, digital twin testing, and spectrum exploration SAN ANTONIO , July 31, 2025 /PRNewswire/ -- Frost & Sullivan is proud to recognize Keysight Technologies with the 2025 Global Company of the Year award in the 6G test and measurement industry. This honor highlights Keysight's exceptional performance in innovation, strategic execution, and market leadership, affirming its role as a trusted partner driving the global shift from 5G to 6G.

ROCHESTER, N.Y. , July 31, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses, waveguides, and augmented reality (AR) technologies, is pleased to announce that the Company will host a conference call regarding its second quarter 2025 operating results at 4:30 PM Eastern Time (ET), August 14, 2025.

NEW YORK , July 31, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CyberArk Software Ltd. (NASDAQ: CYBR)'s sale to Palo Alto Networks for $45.00 in cash and 2.2005 shares of Palo Alto common stock for each CyberArk share.

Aurora Innovation, Inc. (NASDAQ:AUR ) Q2 2025 Earnings Conference Call July 30, 2025 5:00 PM ET Company Participants Christopher Urmson - Co-Founder, CEO & Non-Independent Executive Chairman David Maday - Chief Financial Officer Stacy Feit - Vice President of Investor Relations Conference Call Participants Aman S. Gupta - Goldman Sachs Group, Inc., Research Division Andres Juan Sheppard-Slinger - Cantor Fitzgerald & Co., Research Division Christopher Alan Pierce - Needham & Company, LLC, Research Division Cole Alexander Couzens - Wolfe Research, LLC Colin William Rusch - Oppenheimer & Co. Inc., Research Division Douglas William Dutton - Evercore ISI Institutional Equities, Research …

Carvana Co. (NYSE:CVNA) shares surged almost 20% as its second quarter results beat Wall Street estimates on the top and bottom lines. The used car eCommerce platform posted revenue of $4.84 billion, up 42% year-over-year and ahead of estimates of $4.53 billion.

Shares of Microsoft (NASDAQ:MSFT) popped 4.78% over the past five trading sessions, bolstered largely by the company's strong Q2 earnings, which were announced after the market close on July 30.

AGNC preferreds remain attractive for income investors, offering high yields and improved equity coverage despite recent book value declines. Floating-rate AGNC preferreds are unlikely to see significant price drops if the Fed cuts rates, as credit spreads matter more than short-term rates. Redemption risk for floating-rate preferreds is low and price impact minimal, making AGNCN, AGNCO and others compelling high-quality income holdings.

The average of price targets set by Wall Street analysts indicates a potential upside of 36.8% in Hillman Solutions Corp. (HLMN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in GDS Holdings (GDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The mean of analysts' price targets for Dyne Therapeutics (DYN) points to a 285.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

After reaching an important support level, Medpace Holdings, Inc. (MEDP) could be a good stock pick from a technical perspective. MEDP recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

The mean of analysts' price targets for Zevra Therapeutics (ZVRA) points to an 117.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 142.7% upside potential for uniQure (QURE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 29.4% upside potential for SiriusPoint (SPNT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

LOS ANGELES , July 31, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Replimune Group, Inc. ("Replimune" or "the Company") (NASDAQ: REPL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 22, 2024 and July 21, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before September 22, 2025.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

InterDigital (IDCC) came out with quarterly earnings of $6.52 per share, beating the Zacks Consensus Estimate of $3.36 per share. This compares to earnings of $4.57 per share a year ago.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.